Skip to main content
. 2021 Feb 1;40(11):1927–1941. doi: 10.1038/s41388-020-01577-5

Fig. 1. MET signalling.

Fig. 1

HGF binding to MET triggers MET dimerisation and phosphorylation. Several signalling pathways are then activated, leading to the activation of signals including ERK1/2, STAT3, PI3K and Rac1. Cells respond in increasing their proliferation, migration and/or survival. In parallel, HGF binding to MET triggers its internalisation. MET is still bound to HGF and continues to signal on endosomes. MET internalisation has been shown to be required to sustain its signalling. MET slowly gets degraded, leading to signal termination but oncogenic MET mutants are protected against degradation and trigger persistent endosomal signalling, contributing to their oncogenicity.